Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Spaner

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Cancer Medicine|March 8, 2019
Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trialDavid E Spaner, Lindsay McCaw, Guizhei Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2005
A phase I/II trial of oxidized autologous tumor vaccines during the "watch and wait" phase of chronic lymphocytic leukemiaDavid E Spaner, Caitlin Hammond, Jenny Mena, et al.
Cancer Research|February 20, 2007
Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agentsYonghong Shi, Dionne White, Liwei He, et al.
Ebiomedicine|December 10, 2016
Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia CellsLindsay McCaw, Yonghong Shi, Guizhi Wang, et al.
Blood|August 29, 2007
Extracellular calcium sensing promotes human B-cell activation and functionCaitlin M Hammond, Dionne White, Jelena Tomic, et al.
Cancer Medicine|November 18, 2021
Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trialDavid E Spaner, Yuxuan Luo, Guizhei Wang, et al.
Journal of Leukocyte Biology|May 6, 2010
The role of CD200 in immunity to B cell lymphomaKarrie K Wong, Ismat Khatri, Suchinta Shaha, et al.
Cancer Research|August 10, 2012
Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised miceKarrie K Wong, Fred Brenneman, Alden Chesney, et al.
Frontiers in Oncology|April 28, 2023
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib <i>in vitro</i> and <i>in vivo</i>David E Spaner, Tina YuXuan Luo, Guizhi Wang, et al.
International Journal of Oncology|May 17, 2013
Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemiaMehran Haeri, Youjun Li, Yanmei Li, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Cancer Medicine|March 8, 2019
Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trialDavid E Spaner, Lindsay McCaw, Guizhei Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2005
A phase I/II trial of oxidized autologous tumor vaccines during the "watch and wait" phase of chronic lymphocytic leukemiaDavid E Spaner, Caitlin Hammond, Jenny Mena, et al.
Cancer Research|February 20, 2007
Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agentsYonghong Shi, Dionne White, Liwei He, et al.
Ebiomedicine|December 10, 2016
Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia CellsLindsay McCaw, Yonghong Shi, Guizhi Wang, et al.
Blood|August 29, 2007
Extracellular calcium sensing promotes human B-cell activation and functionCaitlin M Hammond, Dionne White, Jelena Tomic, et al.
Cancer Medicine|November 18, 2021
Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trialDavid E Spaner, Yuxuan Luo, Guizhei Wang, et al.
Journal of Leukocyte Biology|May 6, 2010
The role of CD200 in immunity to B cell lymphomaKarrie K Wong, Ismat Khatri, Suchinta Shaha, et al.
Cancer Research|August 10, 2012
Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised miceKarrie K Wong, Fred Brenneman, Alden Chesney, et al.
Frontiers in Oncology|April 28, 2023
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib <i>in vitro</i> and <i>in vivo</i>David E Spaner, Tina YuXuan Luo, Guizhi Wang, et al.
International Journal of Oncology|May 17, 2013
Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemiaMehran Haeri, Youjun Li, Yanmei Li, et al.
Pageof 5